Valuation: PHARMING GROUP

Market Cap 74Cr 65Cr 61Cr 56Cr 104.24Cr 7.14TCr 104.68Cr 733.93Cr 283.22Cr 3.63TCr 279.54Cr 273.33Cr 12TCr P/E 2026 *
33.7x
P/E 2027 * 25x
Enterprise Value 70Cr 61Cr 57Cr 52Cr 98Cr 6.69TCr 98Cr 687.88Cr 265.45Cr 3.4TCr 262Cr 256.18Cr 11TCr EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.63x
Free-Float
98.05%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 04/03/2025
Director of Finance/CFO 58 01/10/2025
Chief Tech/Sci/R&D Officer 54 01/06/2021
Director TitleAgeSince
Director/Board Member 71 11/12/2020
Director/Board Member 62 11/12/2020
Director/Board Member 60 19/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.04%+3.34%+53.32%+100.52% 1,02800Cr
-0.09%+1.66%+53.24%+66.45% 65TCr
-0.02%+2.66%+18.65%+71.97% 47TCr
-1.22%+3.66%+34.59%+38.81% 35TCr
-0.79%+2.73%+17.73%+25.11% 27TCr
+0.58%+6.76%+10.58%+17.75% 26TCr
+1.55%+2.20%+35.12%+45.91% 21TCr
+0.79%+1.84%-27.55%-56.48% 19TCr
-0.52%+4.45%+31.57%+98.11% 19TCr
Average +0.04%+3.26%+25.25%+45.35% 40.02TCr
Weighted average by Cap. -0.04%+3.09%+34.84%+61.60%

Financials

2026 *2027 *
Net sales 38Cr 33Cr 32Cr 29Cr 54Cr 3.68TCr 54Cr 378.09Cr 145.9Cr 1.87TCr 144.01Cr 140.81Cr 6.02TCr 42Cr 36Cr 34Cr 31Cr 58Cr 4TCr 59Cr 411.55Cr 158.81Cr 2.04TCr 156.75Cr 153.27Cr 6.55TCr
Net income 2.21Cr 1.93Cr 1.82Cr 1.65Cr 3.1Cr 212.17Cr 3.11Cr 22Cr 8.42Cr 107.87Cr 8.31Cr 8.12Cr 347.08Cr 3.36Cr 2.93Cr 2.77Cr 2.51Cr 4.71Cr 322.61Cr 4.73Cr 33Cr 13Cr 164.02Cr 13Cr 12Cr 527.74Cr
Net Debt -4.67Cr -4.07Cr -3.84Cr -3.49Cr -6.54Cr -448.02Cr -6.57Cr -46Cr -18Cr -227.78Cr -18Cr -17Cr -732.91Cr -6.21Cr -5.42Cr -5.11Cr -4.64Cr -8.7Cr -596.03Cr -8.74Cr -61Cr -24Cr -303.03Cr -23Cr -23Cr -975.04Cr
Logo PHARMING GROUP
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The group is developing and commercializing a portfolio of innovative medicines, including small molecules and biologics.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!